SwePub
Sök i LIBRIS databas

  Extended search

L773:1477 0520
 

Search: L773:1477 0520 > (2010-2014) > Oxazole-modified gl...

Oxazole-modified glycopeptides that target arthritis-associated class II MHC Aq and DR4 proteins

Andersson, Ida E., 1982- (author)
Umeå universitet,Kemiska institutionen
Batsalova, Tsvetelina (author)
Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden
Dzhambazov, Balik (author)
Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden
show more...
Edvinsson, Lotta (author)
Umeå universitet,Kemiska institutionen
Holmdahl, Rikard (author)
Karolinska Institutet
Kihlberg, Jan, 1957- (author)
Umeå universitet,Kemiska institutionen
Linusson, Anna, 1970- (author)
Umeå universitet,Kemiska institutionen
show less...
 (creator_code:org_t)
RSC Publishing, 2010
2010
English.
In: Organic and biomolecular chemistry. - : RSC Publishing. - 1477-0520 .- 1477-0539. ; 8:13, s. 2931-2940
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The glycopeptide CII259-273, a fragment from type II collagen (CII), can induce tolerance in mice susceptible to collagen-induced arthritis (CIA), which is a validated disease model for rheumatoid arthritis (RA). Here, we describe the design and synthesis of a small series of modified CII259-273 glycopeptides with oxazole heterocycles replacing three potentially labile peptide bonds. These glycopeptidomimetics were evaluated for binding to murine CIA-associated A(q) and human RA-associated DR4 class II major histocompatibility complex (MHC) proteins. The oxazole modifications drastically reduced or completely abolished binding to A(q). Two of the glycopeptidomimetics were, however, well tolerated in binding to DR4 and they also induced strong responses by one or two DR4-restricted T-cell hybridomas. This work contributes to the development of an altered glycopeptide for inducing immunological tolerance in CIA, with the long-term goal of developing a therapeutic vaccine for treatment of RA.

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view